MedTrace Logo

Pilot Trial Investigating Fermented Whey Supplementation in Healthy Adults

NCT03615339 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2018-08-03

No results posted yet for this study

Summary

Pilot trial: 6-week single arm intervention. Healthy adults (male and female) consume Molkosan (fermented whey) twice a day (AM \& PM).

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Molkosan

Twice daily (AM and PM) 20ml of fermented whey concentrate consumed diluted in 200ml water

Sponsors & Collaborators

  • A. Vogel

    collaborator UNKNOWN

  • University of Aberdeen

    lead OTHER

Principal Investigators

  • Alexandra M Johnstone, Ph.D · Rowett Institute, University of Aberdeen

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-16
Primary Completion
2015-07-07
Completion
2015-07-07

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03615339 on ClinicalTrials.gov